Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998
- PMID: 11266301
- PMCID: PMC2631694
- DOI: 10.3201/eid0701.010116
Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998
Abstract
During 1991 to 1998 at least one Stenotrophomonas maltophilia pulmonary infection was observed in 25 (24%) of 104 cystic fibrosis patients at the same unit of our hospital in Spain. Ribotyping and pulse-field gel electrophoresis (PFGE) characterization of 76 S. maltophilia isolates from these patients indicated an overall clonal incidence of 47.1%, reflecting new strains in 44% of patients with repeated positive cultures for S. maltophilia. Six patients with repeated episodes were persistently colonized (> or = 6 months) with the same strain. S. maltophilia bacterial counts were higher (geometric mean, 2.9 x 10(8) cfu/mL) in patients with repeated episodes than in those with a single episode (8.4 x 10(4) cfu/mL, p < 0.01). Single episodes of S. maltophilia occurred in patients < 10 years of age (43% [6/14]), whereas chronic colonization occurred more frequently in older patients (> 16 years of age).
Similar articles
-
Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment.Infect Control Hosp Epidemiol. 2009 Aug;30(8):753-8. doi: 10.1086/598683. Infect Control Hosp Epidemiol. 2009. PMID: 19583515
-
Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.Pediatr Pulmonol. 2003 Feb;35(2):99-107. doi: 10.1002/ppul.10216. Pediatr Pulmonol. 2003. PMID: 12526070
-
Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis.J Clin Microbiol. 2007 Feb;45(2):529-35. doi: 10.1128/JCM.01444-06. Epub 2006 Nov 29. J Clin Microbiol. 2007. PMID: 17135443 Free PMC article.
-
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.BMC Microbiol. 2011 Jul 5;11:159. doi: 10.1186/1471-2180-11-159. BMC Microbiol. 2011. PMID: 21729271 Free PMC article.
-
Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen.Curr Opin Pulm Med. 2012 Nov;18(6):628-31. doi: 10.1097/MCP.0b013e328358d4f8. Curr Opin Pulm Med. 2012. PMID: 22990659 Review.
Cited by
-
High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital.J Clin Microbiol. 2004 Feb;42(2):693-9. doi: 10.1128/JCM.42.2.693-699.2003. J Clin Microbiol. 2004. PMID: 14766838 Free PMC article.
-
Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.Antimicrob Agents Chemother. 2002 Mar;46(3):665-71. doi: 10.1128/AAC.46.3.665-671.2002. Antimicrob Agents Chemother. 2002. PMID: 11850246 Free PMC article.
-
Infection control in cystic fibrosis.Clin Microbiol Rev. 2004 Jan;17(1):57-71. doi: 10.1128/CMR.17.1.57-71.2004. Clin Microbiol Rev. 2004. PMID: 14726455 Free PMC article. Review.
-
The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia.PLoS Pathog. 2011 Jun;7(6):e1002103. doi: 10.1371/journal.ppat.1002103. Epub 2011 Jun 30. PLoS Pathog. 2011. PMID: 21738470 Free PMC article.
-
Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain.Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3385-96. doi: 10.1007/s10096-012-1707-6. Epub 2012 Aug 2. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22855365
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical